newsfilter
← Latest News
Business Wire·

Guardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026

GH

Research reinforces the significance of genomic and epigenomic profiling approaches to characterize tumor types, identify biomarkers, and support risk stratification Presentations reflect Guardant’s strong